Leo Pharma Investigational Site

Fort Smith, Arkansas 72916

We've found

3 trials

at this facility

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Fort Smith, AR

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Fort Smith, AR

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Fort Smith, AR

Use our guide to learn which trials are right for you!